Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada

✍ Scribed by Gerth, William C; Betschel, Stephen D; Zbrozek, Arthur S

• Book ID: 125401868
• Publisher: BC Decker
• Year: 2014
• Tongue: English
• Weight: 85 KB
• Volume: 10
• Category: Article
• ISSN: 1710-1492
• DOI: 10.1186/1710-1492-10-S1-A42